SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-179458
Filing Date
2022-06-23
Accepted
2022-06-23 09:25:03
Documents
17
Period of Report
2022-06-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d281525d8k.htm   iXBRL 8-K 62084
2 EX-2.1 d281525dex21.htm EX-2.1 672078
3 EX-99.1 d281525dex991.htm EX-99.1 28129
4 EX-99.2 d281525dex992.htm EX-99.2 64450
8 GRAPHIC g281525g0623102156527.jpg GRAPHIC 5157
9 GRAPHIC g281525g0623102156746.jpg GRAPHIC 3669
  Complete submission text file 0001193125-22-179458.txt   1168747

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA fstx-20220622.xsd EX-101.SCH 2854
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE fstx-20220622_lab.xml EX-101.LAB 17168
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fstx-20220622_pre.xml EX-101.PRE 10787
11 EXTRACTED XBRL INSTANCE DOCUMENT d281525d8k_htm.xml XML 3223
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37718 | Film No.: 221033704
SIC: 2834 Pharmaceutical Preparations